Literature DB >> 25545307

Vaccine-induced pityriasis rosea and pityriasis rosea-like eruptions: a review of the literature.

F Drago1, G Ciccarese1, S Javor1, A Parodi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25545307     DOI： 10.1111/jdv.12942

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  19 in total

1.  Interventions for pityriasis rosea.

Authors:  Jose Contreras-Ruiz; Sandra Peternel; Carlos Jiménez Gutiérrez; Ivana Culav-Koscak; Ludovic Reveiz; Maria de Lourdes Silbermann-Reynoso
Journal:  Cochrane Database Syst Rev       Date:  2019-10-30

2.  COVID-19-associated pityriasis rosea in children: Case report and literature review.

Authors:  Maryam Khalili; Bahareh Abtahi-Naeini; Fereshte Rastegarnasab; Kimia Afshar
Journal:  Clin Case Rep       Date:  2022-07-19

3.  Inverse pityriasis rosea secondary to COVID-19 vaccination.

Authors:  Blayne Fenner; Jessica L Marquez; Meredith Pham; Michelle Tarbox
Journal:  Proc (Bayl Univ Med Cent)       Date:  2022-03-09

4.  Erythema nodosum, zoster duplex and pityriasis rosea as possible cutaneous adverse effects of Oxford-AstraZeneca COVID-19 vaccine: report of three cases from India.

Authors:  H Mehta; S Handa; P Malhotra; M Patial; S Gupta; A Mukherjee; D Chatterjee; A Takkar; R Mahajan
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-10-05       Impact factor: 9.228

5.  Pityriasis rosea following CoronaVac COVID-19 vaccination: a case report.

Authors:  E Akdaş; N İlter; B Öğüt; Ö Erdem
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-05-10       Impact factor: 9.228

6.  Pityriasis rosea, COVID-19 and vaccination: new keys to understand an old acquaintance.

Authors:  J M Busto-Leis; G Servera-Negre; A Mayor-Ibarguren; E Sendagorta-Cudós; M Feito-Rodríguez; A Nuño-González; M D Montero-Vega; P Herranz-Pinto
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-05-12       Impact factor: 9.228

7.  Pityriasis rosea after Moderna mRNA-1273 vaccine: A case series.

Authors:  Fabrizio Martora; Gabriella Fabbrocini; Claudio Marasca
Journal:  Dermatol Ther       Date:  2021-12-01       Impact factor: 3.858

8.  Pityriasis Rosea: An Update on Etiopathogenesis and Management of Difficult Aspects - A Reply.

Authors:  Francesco Drago; Giulia Ciccarese
Journal:  Indian J Dermatol       Date:  2017 Jan-Feb       Impact factor: 1.494

9.  Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine.

Authors:  B M Cyrenne; F Al-Mohammedi; J G DeKoven; R Alhusayen
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-05-29       Impact factor: 9.228

Review 10.  Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review.

Authors:  Chii-Shyan Wang; Hsuan-Hsiang Chen; Shih-Hao Liu
Journal:  J Formos Med Assoc       Date:  2022-01-05       Impact factor: 3.871
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.